Business ❯ Finance ❯ Investments ❯ Securities

Public Companies

Law Firm Seeks Gossamer Investors to Lead Securities Suit Over Failed Phase 3 Trial

The recruitment could determine who directs early discovery into alleged trial site problems and the company’s disclosure practices.

Sportradar Faces U.S. Securities Suit After Short‑Seller Reports

Regencell Investors Urged to Seek Lead Role in Securities Class Action by June 23

Rosen Law Firm Reminds PSIX Investors of May 19 Deadline to Seek Lead Plaintiff Role

Nektar Investors Face May 5 Deadline in Securities Suit Over REZOLVE-AA Trial Claims

monday.com Investors Face May 11 Deadline to Seek Lead Role in Securities Class Action

ImmunityBio Investors Urged to Seek Lead Role in Suit After FDA Rebuke Over Anktiva Ads

Camping World Investors Face May 11 Deadline in Securities Class Action

Gossamer Bio Investors Sought to Lead Lawsuit After Seralutinib Trial Failure

Soleno Therapeutics Investors Face May 5 Deadline to Seek Lead Role in Securities Class Action

Oddity Tech Investors Urged to Seek Lead Role in Securities Suit After 49% Plunge

Lufax Investors Get May 20 Deadline to Seek Lead Role in Securities Class Action

Law Firms Press Oddity Tech Investors to Seek Lead Role in Securities Case by May 11

UniQure Investors Face Lead‑Plaintiff Deadline in Securities Fraud Case

Rosen Law Firm Urges Hercules Capital Investors to Seek Lead Role Before May 19 Deadline

Mereo Investors Face Lead‑Plaintiff Deadline in Securities Suit Over Setrusumab Trials

Camping World Faces Securities Class Action Over Inventory Claims

Eos Energy Hit With Securities Class Actions After Revenue Miss Triggers 39% Stock Drop

Camping World Sued in Federal Securities Class Action Over Inventory and Demand Claims

Plaintiff Firms Intensify Biotech Securities Suits as Key Deadlines Near for Nektar, uniQure and REGENXBIO